Business
CBD Life Sciences Inc. (CBDL) Announces LOI With New Jersey Dispensary, Unlocking New Revenue Channels & Strategic Growth Opportunities
CBD Life Sciences Inc. (CBDL) Announces LOI With New Jersey Dispensary, Unlocking New Revenue Channels & Strategic Growth Opportunities.
About this update from Cbd Life Sciences Inc.
[{"type":"text","content":"\r\n\r\n \r\n \r\n CBD Life Sciences Inc. (CBDL) Announces LOI With New Jersey Dispensary, Unlocking New Revenue Channels & Strategic Growth Opportunities\r\n \r\n \r\n\r\n\r\nCBD Life Sciences Inc. (CBDL) Announces LOI With New Jersey Dispensary, Unlocking New Revenue Channels & Strategic Growth Opportunities\r\n\r\n\r\n\r\n\r\n\r\nStrategic collaboration expands CBDL's footprint in the booming East Coast cannabis market projected to surpass $33 billion by 2030, while strengthening retail distribution and cross-brand synergies SCOTTSDALE, AZ / ACCESS Newswire / September 23, 2025 / CBD Life Sciences Inc. (OTC:CBDL), through its wholly owned subsidiary, CBD Vault, is proud to announce that it has entered into a Letter of Intent (LOI) with a licensed dispensary in New Jersey. This powerful agreement represents not just product placement, but a transformational partnership that creates two-way retail visibility, accelerates brand recognition, and opens the door to significant new revenue streams in one of the fastest-growing cannabis markets in the United States.\r\n A Dual-Channel Partnership for Scalable GrowthUnlike conventional wholesale agreements, this LOI establishes a mutually beneficial distribution model. Under the terms, CBD Vault's flagship products - including the Company's industry-leading CBD Pain Relief Cream, Pain Relief Roll-On, 3000mg CBD Tinctures, and Delta-8 Gummies - will secure premium shelf space inside a bustling New Jersey dispensary. In return, select products from the dispensary's proprietary line will be stocked and featured in CBDL's own retail locations, creating a cross-pollination of audiences and expanding market reach for both companies.\r\n This two-way approach not only diversifies CBDL's product mix but also positions the Company as a true collaborative partner within the cannabis ecosystem, enhancing long-term relationships and securing recurring sales channels.\r\n Massive Market Potential on the East CoastNew Jersey's cannabis industry is emerging as a powerhouse. Recent research projects the state's market to surpass $2 billion annually by 2026, driven by both recreational legalization and strong consumer demand. The broader U.S. CBD and cannabis sector is forecasted to reach $33 billion by 2030, with wellness-driven CBD categories alone experiencing CAGR growth rates exceeding 14...